Completed
Phase II Study of Efficacy and Safety of HSK39297 Tablet in Treatment of Patients With Primary IgAN
NCT06670352
- Conditions
- Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China
- Nanjing Drum Tower Hospital Nanjing, Jiangsu, China